[3H]MDL100,907 labels 5-HT(2A) serotonin receptors selectively in primate brain

Neuropharmacology

Volumn 37, Issue 9, 1998, Pages 1147-1158

  López Giménez, Juan F ^a   Vilaró, M Teresa ^a   Palacios, José M ^a,b   Mengod, Guadalupe ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b Almirall Prodesfarma SA ^*  (Spain)

Author keywords

5 HT(2A) receptor; 3H MDL100,907; 3H RP62203; Autoradiography; Human brain; In situ hybridization

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; FANANSERIN; KETANSERIN; MESSENGER RNA; MESULERGINE; RADIOLIGAND; SEROTONIN 2A RECEPTOR; SPIPERONE; TRITIUM; DIAGNOSTIC AGENT; ERGOLINE DERIVATIVE; FLUOROBENZENE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN RECEPTOR; SULFOXIDE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MONKEY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; AGED; ANIMAL; BINDING COMPETITION; COMPARATIVE STUDY; GENETICS; IN SITU HYBRIDIZATION; MACACA; METABOLISM; RADIOASSAY;

AGED; AGED, 80 AND OVER; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; CYCLIC S-OXIDES; ERGOLINES; FEMALE; FLUOROBENZENES; HUMANS; IN SITU HYBRIDIZATION; KETANSERIN; MACACA FASCICULARIS; MALE; NAPHTHALENES; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RNA, MESSENGER; TRITIUM;

EID: 0032217035     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00102-6     Document Type: Article

References (58)

1. 2 and β-adrenergic receptor binding sites in the brain of suicide vistims. Arch. Gen. Psychiat. 47, 1038-1047.
2. 2) receptor binding in the frontal cortex of schizophrenics patients. J. Neural Transm. Gen. Sect. 85, 19-29.
3. Baxter, G., Kennet, G., Blaney, F., Blackburn, T., 1995. 5-HT2 receptor subtypes: a family re-united? Trends. Pharmacol. Sci. 16, 105-110.
4. Bennet, J.P., Enna, S.J., Bylund, D.B., Gillin, J.C., Wyatt, R.J., Snyder, S.H., 1979. Neutransmitter receptors in frontal cortex of schizophrenics. Arch. Gen. Psychiat. 36, 927-934.
5. Biegon, A., Kargman, S., Snyder, L., McEwen, B.S., 1986. Characterization and localization of serotonin receptors in human brain postmortem. Brain Res. 363, 91-98.
6. 2A receptor mRNA in human brain. Brain Res. 676, 157-168.
7. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15 (5), 442-455.
8. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 2099-3108.
9. Cross, A.J., Slater, P., Perry, E.K., Perry, R.H., 1988. An autoradiographic analysis of serotonin receptors in human temporal cortex: changes in Alzheimer-type dementia. Neurochem. Int. 13, 89-96.
10. 2A receptors in schizophrenia. Schizophr. Res. 21, 133-139.
11. 2 receptors and the serotonin transporter in the schizophrenic brain. Behav. Brain Res. 73, 169-175.
12. 2 receptors in dementia of the Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus. J. Neural. Transm. 2, 129-137.
13. 2A receptor antagonist. Society for Neuroscience, St. Louis, MO, Abstr. 427.19.
14. 2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum. Genet. 97, 614-619.
15. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res. 507, 208-215.
16. 2 receptors of the human brain postmortem. Brain Res. 519, 223-227.
17. 2 receptor binding in patients with chronic schizophrenia. Psychopharmacology (Berl.) 112, S35-S39.
18. 4 receptor. Eur. J. Pharmacol. 314, 229-233.
19. 2 recognition sites. Brain Res. 376, 97-107.
20. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., Humphrey, P.P.A., 1994. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
21. 2 sites in cortex and amygdala. Brain Res. 614, 37-44.
22. 2R). Neuropsychopharmacology 10, 56s.
23. Iqbal, N., van Praag, H.M., 1995. The role of serotonin in schizophrenia. Eur. Neuropsychopharmacol. 11, 23.
24. Johnson, M.P., Loncharich, R.J., Baez, M., Nelson, D.L., 1994. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol. Pharmacol. 45, 277-286.
25. 2A receptor ligand. Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 205-209.
26. 2 receptor from a human to a rat pharmacology. FEBS Lett. 307, 324-328.
27. 2A antagonist with a favorable CNS safety profile. J. Pharmacol. Exp. Ther. 277, 968-981.
28. Kinon, B. J., Lieberman, J.A., 1996. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124, 2-34.
29. Laurelle, M., Abi-Darghman, A., Casanova, M.F., Toti, R., Weinberger, D.R., Kleinman, J.E., 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study. Arch. Gen. Psychiat. 50, 810-818.
30. 2 receptor binding sites. Mol. Pharmacol. 21, 301-314.
31. 3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings. Eur. J. Pharmacol. 134, 373-375.
32. 2 receptors. Psychopharmacology 112, S40-S54.
33. 2 receptors and serotonin uptake sites in neocortex of rhesus monkey. J. Comp. Neurol. 280, 27-42.
34. Lidow, M.S., Goldman-Rakic, P.S., Gallager, D.W., Geschwind, D.H., Rakic, P., 1989. Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey. Neuroscience 32(3), 609-627.
35. 3H]MDL 100,907. Naunyn-Schmiedeberg's Arch. Pharmacol. 356, 446-454.
36. 2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 642, 281-289.
37. 2A receptors with positron emission tomography. Life. Sci. 58, 187-192.
38. 2 receptor antagonist. In vitro and ex vivo selectivity profile. Eur. J. Pharmacol. 233, 29-35.
39. 3H]RP62203 binding in the rat brain. Eur. J. Pharmacol. 233, 37-45.
40. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiat. 43, 954-959.
41. 2A receptor antagonist. Eur. J. Pharmacol. 259, 137-141.
42. 2A receptor system. Med. Chem. Res. 6, 1-10.
43. i values. J. Pharmacol. Exp. Ther. 251, 238-246.
44. Mengod, G., Vilaró, M.T., Raurich, A., López-Giménez, J.F., Cortés, R., Palacios, J.M., 1996. 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors. Histochem. J. 28, 747-758.
45. 2 receptor: structurally specific differentiation by ergolines and tryptamines. J. Pharmacol. Exp. Ther. 265 (3), 1272-1279.
46. Pasqualetti, M., Nardi, I., Ladinsky, H., Marazziti, D., Cassano, G.B., 1996. Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Brain. Res. Mol. Brain. Res. 39 (1-2), 223-233.
47. Pazos, A., Hoyer, D., Palacios, J.M., 1984. The binding of serotoninergic ligands to the porcine choroid plexus: characterization of a new type of recognition site. Eur. J. Pharmacol. 106, 539-546.
48. Pazos, A., Probst, A., Palacios, J.M., 1987. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21 (1), 123-139.
49. 3H]spiroperidol. Mol. Pharmacol. 16, 687-699.
50. Rakic, P., Goldman-Rakic, P.S., Gallager, D., 1988. Quantitative autoradiography of major neurotransmitter receptors in the monkey striate and extrastriate cortex. J. Neurosci. 8 (10), 3670-3690.
51. 2 receptors in senile dementia of the Alzheimer type. Neurosci. Lett. 44, 47-51.
52. 3H]ketanserin recognition sites in rat striatum. J. Neurochem. 49, 1833-1838.
53. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur. J. Pharmacol. 273, 273-279.
54. 2A receptors in antipsychotic activity. Life Sci. 56, 2209-2222.
55. Schotte, A., Maloteaux, J.M., Laduron, P.M., 1983. Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res. 276, 231-235.
56. Schreiber, R., Brocco, M., Millan, M.J., 1994. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur. J. Pharmacol. 264, 99-102.
57. 2 receptor antagonist MDL 100,907 as a putative atypical antipsycotic: behavioral, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther. 266, 684-691.
58. Williams, J., Spurlock, G., McGuffin, P., Mallet, J., Nöthen, M.M., Gill, M., Aschauer, H., Nylander, P.-O., Macciardi, F., Owen, M.J., 1996. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet 347, 1294-1296.